Simeon George insider trades
Open-market stock purchases and sales by Simeon George, Unknown at CRISPR Therapeutics AG, from SEC Form 4 filings since Feb 10, 2014.
Track record: 44% of 9 scored buys are up 5% or more since purchase, averaging -3%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 14, 2026 | CRSP CRISPR Therapeutics AG | Sold | $720K |
| Oct 14, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | $420K |
| Oct 14, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought | $10.1M |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought | $10.1M |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought | $7.1M |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 10, 2026 | NKTX Nkarta, Inc | Bought (not open market) | — |
| Jun 9, 2026 | DSGN Design Therapeutics, Inc | Bought (not open market) | — |
| Jun 5, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
Companies traded
- CRSP CRISPR Therapeutics AG: 4 buys, 1 sale, last Oct 14, 2026
- ADRX ADARx Pharmaceuticals, Inc: 3 buys, last Sep 28, 2026
- NKTX Nkarta, Inc: 4 buys, last Jun 10, 2026
- DSGN Design Therapeutics, Inc: 4 buys, last Jun 9, 2026
- NKTK Nkarta, Inc: other filings, last Jun 7, 2023
- TPTX Turning Point Therapeutics, Inc: 3 buys, last Aug 17, 2022
- PRNB Principia Biopharma Inc: 2 buys, last Sep 28, 2020
- GNCA Genocea Biosciences, Inc: 1 buy, last Feb 10, 2014